Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Amortizatization of Intangibles (2010 - 2026)

Updated

Jazz Pharmaceuticals (JAZZ) posted Amortizatization of Intangibles of $170 million for Q2 2026, up 4.9% from $162.1 million a year earlier but down 1.3% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Amortizatization of Intangibles at Jazz Pharmaceuticals was $680.41 million, up 7.5% year-over-year; for FY2025, it was $654.66 million, up 4.4% from FY2024.

  • Annual Amortizatization of Intangibles has increased for five consecutive years, with a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
  • In prior years, Jazz Pharmaceuticals' Amortizatization of Intangibles was $627.31 million in FY2024 (+3.1%), $608.28 million in FY2023 (+1.5%), $599.17 million in FY2022 (+14.0%) and $525.77 million in FY2021 (+102.5%).
  • Quarterly Amortizatization of Intangibles has run from a low of $137.39 million in Q4 2022 to a high of $172.3 million in Q1 2026 over five years.
  • On a year-over-year basis, Amortizatization of Intangibles has increased in each of the last five quarters, with growth averaging 5.0% over the last eight quarters.
  • The strongest year-over-year quarter for Amortizatization of Intangibles in the past five years was Q1 2022, with growth of 152.4%; the weakest was Q1 2023, with a decline of 13.0%.
  • According to Business Quant data, Amortizatization of Intangibles for the three prior quarters was $172.3 million (Q1 2026), $169.74 million (Q4 2025) and $168.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Jazz Pharmaceuticals 15.30 Bn 9.12 Bn 1.09 Bn 170.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 170.00 Mn
Mar 31, 2026 172.30 Mn
Dec 31, 2025 169.74 Mn
Sep 30, 2025 168.37 Mn
Jun 30, 2025 162.10 Mn
Mar 31, 2025 154.40 Mn
Dec 31, 2024 158.90 Mn
Sep 30, 2024 157.46 Mn
Jun 30, 2024 155.22 Mn
Mar 31, 2024 155.73 Mn
Dec 31, 2023 151.55 Mn
Sep 30, 2023 154.88 Mn
Jun 30, 2023 152.06 Mn
Mar 31, 2023 149.79 Mn
Dec 31, 2022 137.39 Mn
Sep 30, 2022 141.23 Mn
Jun 30, 2022 148.46 Mn
Mar 31, 2022 172.09 Mn
Dec 31, 2021 157.29 Mn
Sep 30, 2021 159.80 Mn
API Access

Jazz Pharmaceuticals Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=JAZZ&period=max&api_key=YOUR_API_KEY